Valitor Announces Upcoming Presentations at the Ophthalmology Futures Retina Forum and Euretina Conference, Including New Data for its Long-Acting Anti-VEGF Drug Candidate for Wet AMD, VLTR-559 > ...

(Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first participants in its Phase 1 ...

Launched to give patients, families, and experts a greater voice, NETHERTON NOW has become a global platform shining a spotlight on the painful realities of Netherton Syndrome (NS), a rare and ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will ...

Chemomab Presentation at H.C. Wainwright 27th Annual Global Investment Conference ...

The presentations at the Wells Fargo and Morgan Stanley conferences will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” ...

Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors. Immuneering’s ...

Live webcasts and replays of the Cantor and H.C. Wainwright fireside chats will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ...

With two active production facilities, Kraig Labs has established parallel operations designed to ensure continuous rearing cycles of its specialized recombinant spider silk silkworms. This dual-site ...

“Mountain Shot is a crafted experience infused with the natural complexities of mushrooms,” says Jessie Unruh, Director of Marketing for Breckenridge Distillery. “It is a toast to nature, friendship ...

Following these transactions, Mr. Matuszewski owns 1,145,362 shares of BioStem Technologies stock. For more information about the purchases, please visit the OTCID disclosure website HERE under ...

Through this multi-phased transaction, BrainsWay aims to expand its long-term total addressable market.